Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
2.
Eur J Endocrinol ; 189(1): 87-95, 2023 Jul 20.
Artículo en Inglés | MEDLINE | ID: mdl-37345849

RESUMEN

OBJECTIVE: The optimal approach to the surveillance of non-functioning pituitary microadenomas (micro-NFPAs) is not clearly established. Our aim was to generate evidence on the natural history of micro-NFPAs to support patient care. DESIGN: Multi-centre, retrospective, cohort study involving 23 endocrine departments (UK NFPA consortium). METHODS: Clinical, imaging, and hormonal data of micro-NFPA cases between January, 1, 2008 and December, 21, 2021 were analysed. RESULTS: Data for 459 patients were retrieved [median age at detection 44 years (IQR 31-57)-152 males/307 females]. Four hundred and nineteen patients had more than two magnetic resonance imagings (MRIs) [median imaging monitoring 3.5 years (IQR 1.71-6.1)]. One case developed apoplexy. Cumulative probability of micro-NFPA growth was 7.8% (95% CI, 4.9%-8.1%) and 14.5% (95% CI, 10.2%-18.8%) at 3 and 5 years, respectively, and of reduction 14.1% (95% CI, 10.4%-17.8%) and 21.3% (95% CI, 16.4%-26.2%) at 3 and 5 years, respectively. Median tumour enlargement was 2 mm (IQR 1-3) and 49% of micro-NFPAs that grew became macroadenomas (nearly all >5 mm at detection). Eight (1.9%) patients received surgery (only one had visual compromise with surgery required >3 years after micro-NFPA detection). Sex, age, and size at baseline were not predictors of enlargement/reduction. At the time of detection, 7.2%, 1.7%, and 1.5% patients had secondary hypogonadism, hypothyroidism, and hypoadrenalism, respectively. Two (0.6%) developed hypopituitarism during follow-up (after progression to macroadenoma). CONCLUSIONS: Probability of micro-NFPA growth is low, and the development of new hypopituitarism is rare. Delaying the first follow-up MRI to 3 years and avoiding hormonal re-evaluation in the absence of tumour growth or clinical manifestations is a safe approach for micro-NFPA surveillance.


Asunto(s)
Adenoma , Hipopituitarismo , Neoplasias Hipofisarias , Masculino , Femenino , Humanos , Adulto , Persona de Mediana Edad , Neoplasias Hipofisarias/diagnóstico por imagen , Neoplasias Hipofisarias/epidemiología , Neoplasias Hipofisarias/complicaciones , Estudios Retrospectivos , Estudios de Cohortes , Adenoma/diagnóstico por imagen , Adenoma/epidemiología , Hipopituitarismo/complicaciones , Reino Unido/epidemiología
3.
BMJ Case Rep ; 12(9)2019 Sep 18.
Artículo en Inglés | MEDLINE | ID: mdl-31537596

RESUMEN

We present an unusual case of skull base osteomyelitis in an 88-year-old woman. She presented with gradual onset unilateral headache and diplopia. On examination, there was evidence of a left-sided Horner's and ipsilateral sixth nerve palsy. In addition to persistent raised inflammatory markers, an MRI neck identified signal change in the petrous bone confirming a diagnosis of skull base osteomyelitis. Skull base osteomyelitis should be considered in presentations of subacute raised inflammatory markers in the context of ipsilateral cranial nerve signs.


Asunto(s)
Síndrome de Horner/diagnóstico , Osteomielitis/complicaciones , Hueso Petroso/microbiología , Base del Cráneo/microbiología , Enfermedades del Nervio Abducens/diagnóstico , Enfermedades del Nervio Abducens/etiología , Administración Intravenosa , Anciano de 80 o más Años , Carbapenémicos/administración & dosificación , Carbapenémicos/uso terapéutico , Diplopía/diagnóstico , Diplopía/etiología , Femenino , Cefalea/diagnóstico , Cefalea/etiología , Humanos , Imagen por Resonancia Magnética/métodos , Osteomielitis/tratamiento farmacológico , Hueso Petroso/diagnóstico por imagen , Hueso Petroso/patología , Base del Cráneo/diagnóstico por imagen , Base del Cráneo/patología , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...